More Data on the Neuroactive Steroid Zuranolone for Postpartum Depression
While we have heard a lot about brexanolone, marketed by Sage Therapeutics as Zulresso, for the treatment of postpartum depression, an oral version of this novel antidepressant – SAGE 217 or zuranolone – has been finishing up its Phase 3 trials. Like brexanolone, SAGE-217 is a neuroactive steroid, an analogue of allopregnanolone which is a [...]
The post More Data on the Neuroactive Steroid Zuranolone for Postpartum Depression appeared first on MGH Center for Women's Mental Health.
from MGH Center for Women's Mental Health https://ift.tt/3bYaoDd
via https://ift.tt/33YfKfD https://gani.vn/ #thucphamchucnanggani #gani.vn https://gani-blogvn.blogspot.com/ https://gani.vn/
Nhận xét
Đăng nhận xét